ArticleCurrent medical imaging2025
Machine Learning Model to Predict Iodine Contrast Media-Related Acute Adverse Reaction in Patients Without a Similar History for Enhanced CT.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe objective is to develop and compare risk prediction models for Iodine Contrast Media (ICM)-related Acute Adverse Reactions (AAR) in patients without a prior history of such reactions, and to construct a nomogram based on the superior model.
methods546 patients without a history of ICM-related AAR who underwent ICM administration during CT contrast-enhanced scan were retrospectively enrolled, and divided into training (n=234), test (n=101), and external validation (n=211) sets. Clinical, medication information, and environmental factors were collected. Features were selected by univariate logistical analysis and least absolute shrinkage and selection operator, and four Machine Learning (ML) models, including Logistic Regression (LR), decision tree, k-nearst neighbors and linear support vector classification were used to construct ICM-related AAR risk prediction models were developed and evaluated using AUC, accuracy and F1 score. A nomogram was constructed based on the superior model.
resultsHistory of ICM exposure and allergy due to other factors, hypertension, type of ICMs, ICM dose, oral metformin, hyperglycaemia, and glomerular filtration rate were selected for modeling (all p < 0.05). The LR model demonstrated superior performance, with AUCs of 0.894 (test set) and 0.814 (external validation), and was used to construct a clinically applicable nomogram. DISCUSSION: The LR-based model effectively predicts ICM-related AAR risk using readily available clinical variables. It offers a practical tool for identifying high-risk patients prior to ICM administration, facilitating preventive measures.
conclusionLR can predict the risk of ICM-related AAR well in patients without a history of ICM-related AAR, and the corresponding nomogram is provided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.